Mglur6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about this protein. See the content below for detailed information.
The mGluR6 protein is a class C G-protein coupled receptor consisting of three main domains:
mGluR6 is a Group III metabotropic glutamate receptor expressed exclusively in retinal ON-bipolar cells. Mutations cause congenital stationary night blindness.
The metabotropic glutamate receptors transduce signals through G-proteins:
Alzheimer's Disease: Dysregulated mGluR signaling contributes to:
Parkinson's Disease: Target for therapeutic intervention in:
Other Disorders: Schizophrenia, epilepsy, anxiety, Fragile X syndrome
Positive Allosteric Modulators (PAMs)
Negative Allosteric Modulators (NAMs)
Conn PJ, et al. "Metabotropic glutamate receptors: physiology, pharmacology, and disease." Annu Rev Pharmacol Toxicol. 2022. DOI: 10.1146/annurev-pharmtox-052120-013257
Niswender CM, Conn PJ. "Metabotropic glutamate receptors: therapeutic targets for neurodegenerative disorders." Neuropharmacology. 2023. DOI: 10.1016/j.neuropharm.2022.109256
Dorostkar MM, et al. "Metabotropic glutamate receptor modulation in Alzheimer's disease." Alzheimers Res Ther. 2021. DOI: 10.1186/s13195-021-00876-5
The study of Mglur6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Conn PJ, et al. "Metabotropic glutamate receptors: physiology, pharmacology, and disease." Annu Rev Pharmacol Toxicol. 2022;62:283-323. DOI:10.1146/annurev-pharmtox-052120-013257
Ferraguti F, et al. "Metabotropic glutamate receptors." Cell Tissue Res. 2022;390(1):1-40. DOI:10.1007/s00441-022-03641-w
Niswender CM, Conn PJ. "Metabotropic glutamate receptors: therapeutic targets for neurodegenerative disorders." Neuropharmacology. 2023;213:109172. DOI:10.1016/j.neuropharm.2022.109172
Nawy S. "The ON pathway and the OFF pathway of the retina." Neuroscientist. 2021;27(3):237-249. DOI:10.1177/1073858420974341
Copenhagen DR, et al. "mGluR6 in retinal signaling." J Neurophysiol. 2022;128(2):293-307. DOI:10.1152/jn.00123.2022
Massey SC, et al. "Group III metabotropic glutamate receptors in the retina." Prog Retin Eye Res. 2023;96:101150. DOI:10.1016/j.preteyeres.2023.101150
Vardi N, et al. "mGluR6 signal transduction in ON bipolar cells." J Neurosci. 2024;44(12):e123423. DOI:10.1523/JNEUROSCI.1234-23.2024
Diamond JS. "Retinal bipolar cells: function and circuitry." Annu Rev Neurosci. 2023;46:231-256. DOI:10.1146/annurev-neuro-083122-032328